1. Home
  2. EBS

as 11-21-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Founded: 1998 Country:
United States
United States
Employees: N/A City: GAITHERSBURG
Market Cap: 459.6M IPO Year: 2006
Target Price: $14.00 AVG Volume (30 days): 1.6M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.98 EPS Growth: N/A
52 Week Low/High: $1.42 - $15.10 Next Earning Date: 11-06-2024
Revenue: $1,125,500,000 Revenue Growth: 2.05%
Revenue Growth (this year): 7.98% Revenue Growth (next year): 6.62%

EBS Daily Stock ML Predictions

Stock Insider Trading Activity of Emergent Biosolutions Inc. (EBS)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
DeGolyer Donald W EBS Director Nov 12 '24 Sell $10.91 25,000 $272,750.00 111,100
White Marvin L EBS Director Nov 11 '24 Sell $11.97 14,287 $171,015.39 54,092

Share on Social Networks: